RiverFort Global Capital arranges a convertible financing agreement for Blackhawk Growth Corp., a CSE-listed company, for up to C$10 million

Fasken advised RiverFort Global Capital Ltd. on a convertible credit facility financing agreement with Blackhawk Growth Corp. for up to C$10 million. The proceeds are intended to be used to support Blackhawk’s research in Trip Pharma. Blackhawk will draw down an initial tranche of C$2.5 million, maturing on November 22, 2023. Subsequent drawdowns will be subject to the satisfaction of closing conditions. In connection with each drawdown, warrants will also be issued.

We advised RiverFort Global Capital Ltd. with a team led by Jodi Katz, and included Thomas Wexler and Gabrielle Motuz.